Citation Impact
Citing Papers
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
2011
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
2015
Nonclassic Congenital Adrenal Hyperplasia
2010
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review
2010
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
What every physician should know about polycystic ovary syndrome
2008
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
2011
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
2010
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
2011
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
2002
The adrenal and polycystic ovary syndrome
2007
Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system
2012
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
2006
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
2012
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome
2006
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Effects of prolactin on platelet activation and blood clotting
2013 StandoutNobel
DHEA, DHEAS and PCOS
2014
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long‐acting repeatable octreotide) in the primary therapy of patients with acromegaly
2007
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
2008
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Defining ConstantVersusVariable Phenotypic Features of Women with Polycystic Ovary Syndrome Using Different Ethnic Groups and Populations
2006
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome
2008
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
2014
Polycystic Ovary Syndrome
1995 Standout
Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome
2004
Fertility and infertility: Definition and epidemiology
2018 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
2012
Acne vulgaris
2011 Standout
Polycystic Ovary Syndrome
2005 Standout
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
2011
Polycystic ovary syndrome and hyperprolactinemia are distinct entities
2007
Adolescent Anovulation: Maturational Mechanisms and Implications
2013
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS
2007
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
2012
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
2007
Androgen excess: Investigations and management
2016
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS
1989
Surgical Interventions and Medical Treatments in Treatment-Naïve Patients With Acromegaly: Systematic Review and Meta-Analysis
2014
Polycystic ovary syndrome
2016 Standout
Clinical relevance of macroprolactin
2005
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study
2012
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
2012
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms
2009
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
2009
Visually scoring hirsutism
2009
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
2009
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
2017
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
2015
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Clinical and Biological Phenotypes in Late-Onset 21 Hydroxylase Deficiency
1986
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
2007
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
Polycystic Ovarian Morphology in Normal Women Does Not Predict the Development of Polycystic Ovary Syndrome
2006
A Consensus on Criteria for Cure of Acromegaly
2010
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
2012
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
2012
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline
2019
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
1995
STUDIES OF PROLACTIN SECRETION IN POLYCYSTIC OVARY SYNDROME
1986
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Works of F. Rosato being referenced
Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
2006
Effects of Lanreotide Autogel on Growth Hormone,Insulinlike Growth Factor 1, and Tumor Size in Acromegaly: a 1-Year Prospective Multicenter Study
2008
First‐line octreotide‐LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial
2006
Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern
1984
The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency)
1984
[Hyperprolactinemia: from diagnosis to treatment].
2002
Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients
1986